Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Moderna, Inc. - Common Stock
(NQ:
MRNA
)
32.53
-1.05 (-3.11%)
Streaming Delayed Price
Updated: 12:46 PM EST, Feb 27, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna, Inc. - Common Stock
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
99
100
Next >
Cathie Wood's Ark Ups Tesla Bet With $28M Stock Buy Amid Rebound, Also Loads Up On This Online Game Platform
March 26, 2024
Through its two ETFs, Ark Innovation ETF and ARK Next Generation Internet ETF, Ark bought 163,421 Tesla shares.
Via
Benzinga
Topics
ETFs
Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today
March 25, 2024
Via
Benzinga
Two Hot AI Stocks Lead S&P 500 Monday
March 25, 2024
Super Micro and Micron , two big winners in 2024, led the way Monday.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now
March 23, 2024
These stocks share several things in common.
Via
The Motley Fool
Artificial Intelligence (AI) in Healthcare: 2 Top Stock Picks
March 23, 2024
These particular healthcare stocks are dirt cheap now considering their AI potential.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Behind the Scenes of Moderna's Latest Options Trends
March 22, 2024
Via
Benzinga
Peering Into Moderna's Recent Short Interest
March 14, 2024
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $5,000 Today
March 13, 2024
Via
Benzinga
Moderna Stock: Bull vs. Bear
March 13, 2024
This stock delivered spectacular gains in the past.
Via
The Motley Fool
Is Cathie Wood Buying The Rumor? Ark More Than Doubles Stake In This COVID-19 Vaccine Maker Ahead Of Flurry Of Catalysts
March 21, 2024
Ark, through its flagship Ark Innovation ETF and Ark Genomic Revolution ETF, has been brisk with its acquisition of Moderna shares in March.
Via
Benzinga
Topics
ETFs
Exposures
COVID-19
Cathie Wood's Ark Invest Sells Another Tranche Of Block Shares, Even As Bitcoin Price Stages A Recovery
March 20, 2024
On Wednesday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Block Inc (NYSE:SQ) amidst Bitcoin (CRYPTO: BTC) prices recovering.
Via
Benzinga
Why Moderna Shares Are Falling
March 20, 2024
Moderna shares are trading lower by 2.7% during Wednesday's session. The stock is falling in possible sympathy with BioNTech, which reported worse than expected fourth-quarter earnings.
Via
Benzinga
BioNTech Tumbles As Fourth-Quarter Sales Dive 65% And Miss Forecasts
March 20, 2024
BioNTech also reported plummeting earnings that missed forecasts and issued light 2024 guidance.
Via
Investor's Business Daily
Cathie Wood's Ark Invest Isn't Done Selling Shares Of Jack Dorsey-Led Block Yet — Sheds $7.5M Worth of Stock As Bitcoin Price Drops
March 20, 2024
On Tuesday, Cathie Wood-led Ark Invest offloaded a significant amount of Block Inc (NYSE:SQ) shares amidst a downturn in Bitcoin (CRYPTO: BTC) prices.
Via
Benzinga
Market Whales and Their Recent Bets on MRNA Options
March 08, 2024
Via
Benzinga
Cathie Wood-Led Ark Invest Sheds Shares Of Jack Dorsey's Block And Coinbase As Bitcoin, Ethereum Take A Breather
March 19, 2024
On Monday, Cathie Wood-led Ark Invest made significant trades, notably offloading shares of Coinbase Global Inc (NASDAQ:COIN) and Block Inc (NYSE:SQ), despite
Via
Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought Last Week
March 18, 2024
Wood doesn't worry about short-term share price performance. She bets on the long term.
Via
The Motley Fool
3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise
March 15, 2024
Dive into the potential of precision medicine stocks poised to revolutionize healthcare and offer substantial growth opportunities.
Via
InvestorPlace
Reviving Interest: Moderna
March 13, 2024
Here’s a stock I haven’t thought about in a long time: Covid-mega-beneficiary Moderna, which seems to have a rock-solid price sealing at about $118.
Via
Talk Markets
Cathie Wood's Ark Invest Keeps Dumping Coinbase Shares Amid Bitcoin, Crypto Buzz
March 12, 2024
On Tuesday, Cathie Wood-led Ark Invest made a significant move by offloading a substantial number of shares in Coinbase Global Inc (NASDAQ:COIN), despite Bitcoin (CRYPTO: BTC) reaching new
Via
Benzinga
Natural Gas Prices Are Falling Again. Chinese Indices Are Growing Amid Support From The Central Bank
March 12, 2024
The Dow Jones Index (US30) was up 0.12% at Monday's stock market close. The S&P 500 Index (US500) was down 0.11%. The NASDAQ Technology Index (US100) closed negative 0.41%.
Via
Talk Markets
Topics
Economy
Energy
Stocks
Exposures
Fossil Fuels
Interest Rates
US Equities
Moderna Nears Its First Breakout In Over A Year After Launching Third Cancer Vaccine Test
March 11, 2024
Moderna and Merck are now testing their cancer vaccine in patients with another form of skin cancer.
Via
Investor's Business Daily
What's Going On With Moderna Stock On Monday?
March 11, 2024
Merck's trial with Moderna's V940 for advanced cutaneous squamous cell carcinoma. The neoadjuvant and adjuvant therapy with pembrolizumab, aiming for superior event-free survival. Phase 3 expansion...
Via
Benzinga
Stocks Inch Lower Ahead Of Inflation Data, Gold Takes Breather, Bitcoin's Bull Run Persists: What's Driving Markets Monday?
March 11, 2024
Wall Street opens week with slight dip as investors exercise caution ahead of February's inflation report. Gold pauses, Bitcoin hits $72,000.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 11, 2024
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart...
Via
Benzinga
Exposures
Product Safety
1 (Bad) Reason to Sell Moderna Stock Right Now, and 2 Good Reasons to Buy It
March 11, 2024
Sometimes bad news is a bad reason to sell.
Via
The Motley Fool
Turnaround Plays: 3 Stocks to Buy for a Major Recovery in 2024
March 08, 2024
While most companies that change their plans fail, investors should pay attention to these three turnaround stocks poised for recovery.
Via
InvestorPlace
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
March 07, 2024
Discover the pivotal roles of cancer-fighting biotech stocks that are advancing cancer research and subsequently, their financial growth.
Via
InvestorPlace
7 F-Rated Stocks to Sell in March 2024
March 07, 2024
This market is too strong to risk holding F-rated stocks. If you're still seeing these names in your portfolio, it's time to make a move.
Via
InvestorPlace
It’s Time! 3 Failing Biotech Stocks to Sell Right Now
March 05, 2024
The biotech industry offers investors unique investment opportunities but these three are biotechs to sell.
Via
InvestorPlace
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.